Nuvation Bio NUVB
NYSE NUVB
$4.57 -0.12 (-2.56%)
At close: Oct 23, 2026 · 4:00 PM EDT

Nuvation Bio (NUVB) Cost of Revenue (2024 - 2025)

Updated

Nuvation Bio (NUVB) reported Cost of Revenue of $3.35 million for Q3 2025, up 121.1% from $1.52 million a year earlier and up 30.0% from the prior quarter.

Analysis

Nuvation Bio (NUVB) Cost of Revenue (2024 - 2025) Analysis & Trends

Over the twelve months ended Sep 30, 2025, Nuvation Bio's Cost of Revenue came in at $12.24 million, up 327.5% year-over-year; for FY2024, it came in at $7.08 million.

  • Five-year quarterly Cost of Revenue spans a low of $1.35 million in Q2 2024 and a high of $4.22 million in Q4 2024.
  • Per Business Quant data, the three quarters before Q3 2025 came in at $2.58 million (Q2 2025), $2.09 million (Q1 2025) and $4.22 million (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 8.10 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 4.29 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.52 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.58 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.09 Bn
10 Nuvation Bio 1.58 Bn -689.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 3.35 Mn
Jun 30, 2025 2.58 Mn
Mar 31, 2025 2.09 Mn
Dec 31, 2024 4.22 Mn
Sep 30, 2024 1.52 Mn
Jun 30, 2024 1.35 Mn
API Access

Nuvation Bio Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=NUVB&period=max&api_key=YOUR_API_KEY